Uganda has officially launched Lenacapavir for HIV prevention (PrEP), marking an important step in expanding HIV prevention choices.
In this Press Release, ICWEA welcomes the milestone and highlights the importance of ensuring women and girls can fully benefit through equitable access and informed choice.
